Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Lomitapide Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 171,409Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    23/07/2021 Glenmark Life Sciences
    India
    		 M/s Glenmark Life Sciences Limited WC-0310 Lomitapide Mesylate (IH) 2021-01-08 2023-11-23 Plot No.Z-103/I Dahej Sez, Phase-II Dahej, Dist Bharuch, Gujarat
    07/06/2021 Maithri Drugs
    India
    		 M/s Maithri Drugs Pvt ltd WC-0407 Lomitapide Mesylate IH 2020-09-09 2023-06-28 Sy. No. 205, 222 to 226, IDA Bonthapally bonthapally Village Jinnaram mandal medak Dist. Telangana State 502313 India